This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Health Care

Gilead's Earnings: Diving Deeper Into The Numbers With $84,000 Sovaldi Drug

Gilead released its first quarter earnings and the pharmaceuticals company did not disappoint. However, there is a lot more behind the numbers, especially with their $84,000-a-bottle Sovaldi drug.

04/23/14 - 06:30 PM EDT

Hedge Funds Love These 5 Health Care Stocks -- but Should You?

Here's a look at five health care stocks that funds have been adding in the most recent quarter.

04/23/14 - 12:58 PM EDT

Try Jim Cramer's Action Alerts PLUS
Bill Ackman Goes Corporate Raider Route Backing Valeant in Allergan Bid

Bill Ackman Goes Corporate Raider Route Backing Valeant in Allergan Bid

With Bill Ackman backing Valeant Pharmaceuticals $45 billion hostile takeover attempt for Botox maker Allergan, it appears as though activism has entered a new phase.

04/23/14 - 11:50 AM EDT

Video
Gilead's Hepatitis C Drug Solvaldi Delivers Healthy Earnings Gilead's Hepatitis C Drug Solvaldi Delivers Healthy Earnings
  • Tickers in this article:
  • GILD

Gilead delivered healthy earnings thanks to huge sales of its hepatitis C drug Solvaldi, even though insurers are pushing back about the price of the treatment.

04/23/14 - 10:18 AM EDT

Article
April 23 Premarket Briefing: 10 Things You Should Know

April 23 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are mixed; Apple and Facebook to report earnings after the closing bell on Wednesday; AT&T adds more than 1 million subscribers; JetBlue pilots vote to unionize.

04/23/14 - 07:50 AM EDT

Article
How Obamacare Will Play Out for Big Pharma

How Obamacare Will Play Out for Big Pharma

Obamacare could significantly impact on the ability of pharma giants to sustain their pace of curative and life-saving innovations.

04/23/14 - 06:00 AM EDT

Video
Why Mixing Dollars and Doctors Is a Healthy Idea Why Mixing Dollars and Doctors Is a Healthy Idea
  • Tickers in this article:
  • XLV

Approximately one-quarter or your retirement expenses will be spent on healthcare so individuals need to save and invest accordingly, says Douglas Wolford, President of Convergent Wealth Advisors. Wolford says one idea is to start shopping early for a concierge doctor or an Accountable Care Organization (ACO). He also suggests procuring long term care insurance well before you need it. Finally, Wolford advocates keeping up with changes in health laws and practicing preventive medicine.

04/22/14 - 02:25 PM EDT

Article
Amgen, AT&T and Yum! Brands Lead Today's Earnings: Crunching the Numbers

Amgen, AT&T and Yum! Brands Lead Today's Earnings: Crunching the Numbers

Cree, Discover, Gilead Sciences, Intuitive Surgical, Juniper Networks, Skyworks Solutions and VMWare also report earnings after the closing bell today.

04/22/14 - 08:51 AM EDT

Article
April 22 Premarket Briefing: 10 Things You Should Know

April 22 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are lower; Valeant is teaming up with activist investor Bill Ackman in a bid for Allergan; Novartis to buy GlaxoSmithKline's cancer-drug business for $14.5 billion; Netflix posts mixed first-quarter earnings.

04/22/14 - 08:01 AM EDT

Article
Novartis, Glaxo, Lilly in Multi-Billion Dollar Deals

Novartis, Glaxo, Lilly in Multi-Billion Dollar Deals

Swiss pharmaceutical giant Novartis NVS announces a series of multibillion-dollar deals Tuesday.

04/22/14 - 06:32 AM EDT

Article
Emerging 'Superbugs' -- and Why Investors Should Care

Emerging 'Superbugs' -- and Why Investors Should Care

Antibiotic-resistant 'superbugs' are spreading, and drug companies and their investors should take notice.

04/21/14 - 12:23 PM EDT

Article
Sozzi: Nike's Fuelband Runs out of Gas

Sozzi: Nike's Fuelband Runs out of Gas

Nike's decision to scrap its Fuelband wearable device comes as a shock to all tech enthusiasts. In case you missed it, Nike has apparently fired the majority of the team responsible for Fuelband development, a total of 70 out of the 200 that make up the larger Digital Sports division. We share three surprising things that were learned from this shocking decision.

04/21/14 - 10:52 AM EDT

Article
Assessing the Market's Mixed Messages

Assessing the Market's Mixed Messages

The recent large intra-week swings are having investors scratching their heads.

04/21/14 - 10:07 AM EDT

Article
April 21 Premarket Briefing: 10 Things You Should Know

April 21 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are rising; Pfizer reportedly hold informal talks about a merger with AstraZeneca; Kraft Foods recalls 96,000 pounds of hot dogs; Netflix to report earnings; GM boosts production in China.

04/21/14 - 06:47 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.9670 -34.4910 -0.83%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs